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Abstract
Background: Despite extensive efforts devoted to predicting protein-coding genes in genome sequences, many
bona fide genes have not been found and many existing gene models are not accurate in all sequenced eukaryote
genomes. This situation is partly explained by the fact that gene prediction programs have been developed based
on our incomplete understanding of gene feature information such as splicing and promoter characteristics.
Additionally, full-length cDNAs of many genes and their isoforms are hard to obtain due to their low level or rare
expression. In order to obtain full-length sequences of all protein-coding genes, alternative approaches are
required.
Results: In this project, we have developed a method of reconstructing full-length cDNA sequences based on
short expressed sequence tags which is called sequence tag-based amplification of cDNA ends (STACE). Expressed
tags are used as anchors for retrieving full-length transcripts in two rounds of PCR amplification. We have
demonstrated the application of STACE in reconstructing full-length cDNA sequences using expressed tags mined
in an array of serial analysis of gene expression (SAGE) of C. elegans cDNA libraries. We have successfully applied
STACE to recover sequence information for 12 genes, for two of which we found isoforms. STACE was used to
successfully recover full-length cDNA sequences for seven of these genes.
Conclusions: The STACE method can be used to effectively reconstruct full-length cDNA sequences of genes that
are under-represented in cDNA sequencing projects and have been missed by existing gene prediction methods,
but their existence has been suggested by short sequence tags such as SAGE tags.
Background
The nematode Caenorhabditis elegans, which is a well-
established model organism for biomedical research [1],
is the first metazoan whose genome was subject to
whole-genome sequencing [2]. Its gene models were
first predicted using the gene prediction program Gene-
finder (P. Green, unpublished). Over the dozen years
since the completion of the C. elegans genome sequen-
cing project [2], the C. elegans gene set has been curated
by the C. elegans research community and by Worm-
Base curators [1,3-5]. However, the C. elegans gene set
is still far from complete for the following reasons: First,
because Genefinder, like other gene prediction pro-
grams, was developed based on an incomplete under-
standing of gene structures, it suffers from both false
positive and false negative predictions; second, many
bona fide genes, especially those of unknown character,
have been missed. In WormBase http://www.wormbase.
org, the official database for the biology and genomics
of C. elegans, less than 40% of the annotated gene mod-
els are fully confirmed. All others are either partially
supported or not supported at all. Additional gene mod-
els have been revealed in transcriptome sequencing
[6,7], suggesting many gene models remain to be discov-
ered. This situation is also true for other species [8]. In
the human genome, it has been estimated that the most
accurate programs only correctly predict 40% of the
annotated genes [9].
In this project, we explored how to reconstruct full-
length gene models for genes that are not correctly
represented in the current gene set, using expressed
sequence tags obtained in large-scale gene expression
projects. In particular, we attempted to reconstruct
novel C. elegans gene models using SAGE (serial
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analysis of gene expression). The SAGE technique was
originally developed for profiling gene expression
[10,11]. The expression profiles created with SAGE have
a wide range of applications that include therapeutic tar-
get identification in cancerous tissues [12] and others of
biological and medical importance [13]. Recently, SAGE
was applied to probe gene expression in C. elegans by
the C. elegans Gene Expression Consortium http://ele-
gans.bcgsc.bc.ca/home/ge_consortium.html. These
SAGE libraries have been fundamental for the success
of a variety of research projects [14-19]. While SAGE
tags that correspond to existing gene models can be
used to evaluate the abundance of gene expression,
there are a large number of SAGE tags that do not cor-
respond to existing gene models. These SAGE tags sug-
gest the existence of additional coding exons, splice
variants [20], or novel genes.
Results
Tag based reconstruction of full-length cDNA sequence of
novel genes
Expressed sequence tags that cannot be aligned to the
C. elegans virtual transcriptome (i.e., cDNA sequences
of all annotated transcripts) suggest the existence of yet
unannotated genes [13,21]. We have established a proto-
col, termed as “sequence tag-based amplification of
cDNA ends”, or STACE, based on the RACE protocol
[22], to identify potential novel genes. The method can
be used to amplify full-length cDNA transcripts that
have been reverse-transcribed from the mRNA sequence
of novel genes. STACE uses three primer hybridization
sites. The first site (the 5’ site) is a sequence located at
the extreme 5’ end of the target transcript, the second
site (the 3’ site) is downstream of the polyadenylation
sequence, and the third site (the gene-specific site) cor-
responds to the genomic span where the uncharacter-
ized tag maps. The amplicons are then cloned,
sequenced and mapped to the genome. As such, STACE
not only confirms the existence of a novel gene, but also
defines the full-length transcript sequence of the yet
undefined gene.
In this project, in order to get a primer hybridization
site at the extreme 5’ end of the RNA transcripts, we
took advantage of the trans-splice leader 1 (SL1) in C.
elegans, and used its sequence as a primer for our 5’
site. It is appropriate to design the 5’ primer based on
the SL1 sequence because SL1 is trans-spliced to the
extreme 5’ end of nearly 50% of all C. elegans mRNAs
[23,24]. For applications in which the sample transcrip-
tome does not undergo trans-splicing of this nature, a
common oligo anchoring sequence can be ligated to the
5’end of each transcript. An oligo sequence was attached
to the polyadenylation tracks of mRNA through reverse
transcription with a modified oligo d(T) primer that
included a 3’ common sequence (5’ - CCAGACAC-
TATGCTCATACGACGCAGT(16)VN - 3’). This pro-
vided us with a cDNA library containing transcripts that
had a usable 3’ site. Finally, we chose gene-specific sites
by bioinformatically identifying SAGE tags. When
aligned to the C. elegans genome, qualified SAGE tags
do not overlap with existing gene models. For each qua-
lified SAGE tag, a primer was designed and used in con-
junction with a primer complementary to the SL1
sequence to amplify the upstream amplicon. A second
primer was designed and used in conjunction with the
primer complementary to the 3’ common sequence
(above) to amplify the downstream amplicon. The
potential template was amplified, and the amplicon
sequences were mapped to the C. elegans genome using
BLAT [25], which is available at WormBase http://www.
wormbase.org.
Computational selection of SAGE tags that suggest novel
genes
SAGE tags used in this study were selected from 33
SAGE libraries, which were sequenced from different
tissues and developmental stages of C. elegans http://
tock.bcgsc.bc.ca/cgi-bin/sage160. There are altogether
220,770 unique SAGE tags in these libraries. Only
SAGE tags that did not overlap with annotated protein-
coding genes in the WS160 version of the C. elegans
genome map were selected for this project.
We obtained four different sets of SAGE tags for test-
ing, one preliminary set and three test sets (Set 1-3)
(Table 1). The preliminary set, which was arbitrarily
chosen, was used to test the STACE protocol. Set 1
used a longSAGE meta-library as a starting tag set
(16,587 SAGE tags). Set 2 was created from the WS160
version of the mixed stage library (14,701), and Set 3
used SAGE libraries derived from Solexa sequencing of
the SWN21 and SWN22 embryonic samples (359,457
SAGE tags). Solexa SAGE produced more initial SAGE
tags than the previous SAGE libraries because it has
much deeper coverage. Note that the Illumina Solexa
Genome Analyzer produced a SAGE library that is
about 20 times more sensitive than a normal SAGE
library [26].
SAGE libraries were filtered to select SAGE tags for
finding novel genes (Figure 1). The criteria used
included the following: (1) Only SAGE tags that can be
aligned to the C. elegans genome were selected; (2) The
SAGE tags must not overlap with any annotated coding
exon; (3) To avoid tags containing sequencing errors,
SAGE tags must have a frequency of at least three for
every 100,000 reads; (4) To increase the chances of find-
ing novel genes (rather than novel missing exons), the
SAGE tags must not overlap with an intron and have to
be at least 500 bp away from an annotated 5’ or 3’ gene
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boundary; (5) SAGE tags must have a GC content
between 35% and 45%, which is critical for primer
design.
Primers based on SAGE tags were designed to ensure
a reduced possibility of formation of secondary struc-
tures which would inhibit proper annealing of the pri-
mers [27]. For many cases, we trimmed sequences from
either end of the SAGE tags to ensure primer quality.
SAGE tag sequences that could not be used to guide
proper primer design were not used. Primer design was
done using the Primer3 program [28].
cDNA libraries
Two different cDNA libraries were created; one from a
mixed stage population of C. elegans and another one
from embryonic animals. In order to maximize the
number of successful experiments, candidate SAGE tags
were only screened against the developmental library
that corresponded with the time in development that
the tags were originally observed.
New transcripts and novel cDNAs
STACE-identified candidates consist of three categories
based on the alignments of these candidates to the C.
elegans genome (release WS160): (1) novel gene (six
candidates), (2) annotation extension (four candidates),
and (3) non-protein-coding gene overlap (two candi-
dates) (Figure 2; Table 2). Novel genes are proof of
entirely new genes discovered using the STACE method.
The exons of these six new genes are all bordered by
the canonical GT-AG splice signals, as is the case with
most exons [29,30]. Our identification of six novel genes
was based on using the WS160 annotated genome. In
the interim four have been annotated in WS200, while
the other two are still completely novel. One of these
two new gene models was characterized as a full-length
gene model with the STACE method, while the other’s
existence was implied by an upstream amplicon
sequence. Four tested SAGE tag primers produced
results that suggest an extension to the annotated length
of the gene models. These annotated extensions align
perfectly with annotated exons, and imply either addi-
tional exons are transcribed within the gene, or that the
terminal exons are longer than shown by WormBase.
We found a successful STACE result overlapped with
a pseudogene. While this transcript may not be trans-
lated, using STACE we have clearly shown that it is pro-
cessed with introns removed and a polyadenylation track
added to the 3’end. We have also found that a STACE
result overlapped with an annotated ncRNA gene. The
transcript was also processed with a previously unknown
intron excised and a polyadenylation track added.
Altogether, we have reconstructed seven full-length,
true positive cDNA sequences, corresponding to seven
Table 1 SAGE tag numbers for each set through the identification of high value candidate SAGE tags
Total
tags
Mappable
tags
Non-
transcriptome
tags
Tags with
frequency
count >3
Tags absent from gene
boundaries and introns
Tags with
appropriate GC
content
Tags that can
serve as primers
SAGE tag
primers
tested
Set 1 16,587 13,743 3,052 616 418 128 39 30
Set 2 14,701 10,534 4,755 365 41* 19 12 12
Set 3 359,457 32,416 13,542 8,211 469 124 106 96
Figure 1 SAGE tag primer development. SAGE tag pools are put
through various filtrations to produce a source of SAGE tag primers
that are used in STACE experiments. 1) SAGE tag libraries are
downloaded from the MultiSAGE website. 2) All SAGE tags that do
not fully map to the genome as one single uninterrupted alignment
are discarded. 3) SAGE tags that map to annotated transcribed
sequences are discarded. 4) SAGE tags that have a low level of
expression and are possible errors in sequencing are discarded. 5)
SAGE tags that are found to overlap with intronic sequences or
map near a 5’ or 3’ boundary are eliminated. 6) Only tags with GC
content between 35% and 45% are retained. 7) SAGE tags are
edited into primer form. All SAGE tags that are likely to produce
secondary structure (i.e. hairpins, homo-dimers, hetero-dimers) are
discarded. 8) A final list of SAGE tag primers is procured.
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separate gene models (Table 3). All seven cDNAs con-
tain SL1 signals at the 5’ ends and polyadenylation at
the 3’ends. The remaining seven true positive cDNAs
recovered represent the 5’ends of separate gene models,
and these too contain full-length 5’ SL1 signals. Thus, in
this study, we have identified 14 SL1-trans-spliced
cDNA sequences. All 14 cDNA sequences have been
submitted to GenBank (Table 3).
Discussion
In this project, we have developed an experimental
method termed STACE for reconstructing full-length
cDNAs of novel genes. The applicability of STACE has
been demonstrated by defining novel genes in the well-
curated C. elegans genome, using SAGE tags from gene
expression studies. We reconstructed seven novel full-
length cDNAs and seven partial cDNA sequences that
can be merged to existing gene models. Novel genes,
Figure 2 STACE experimental procedure. Template cDNA is used in two separate PCR reactions that utilize primers based on the sequence of
a SAGE tag, the SL1 sequence and modified oligo d(T) primer. The PCRs produce an amplicon representative of the sequence upstream of the
SAGE tag location (PCR product 1), and another that comes from the downstream sequence (PCR product 2). These products are sequenced,
and mapped to the C. elegans genome. Those sequences whose alignments overlap with the SAGE tag used in primer design are considered
true positive STACE results.
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annotation extensions, and non-protein-coding gene
overlaps are represented by the identified cDNA
sequences 3.3 (Figure 3), 3.1 (Figure 4), and P.3 (Figure
5), respectively.
We compared novel cDNAs with C. elegans gene
models predicted using AUGUSTUS [31], mGENE [32],
TWINSCAN [33] and FGENESH++ [34], which are
available at WormBase. All cDNAs, which were detected
using STACE, when aligned to the C. elegans genome
overlap to a certain extent with predicted gene models.
The novel full-length cDNA 3.3 aligned well with a pre-
diction from TWINSCAN and with a prediction made
Table 2 Result classifications for all sets of tested SAGE tag primers
Novel
Genes
Annotation
Extensions
Non-Protein Gene
Overlap
Number of Candidate cDNAs/Number of SAGE tag Primers
Tested
Preliminary
Set
1 0 2 3/6 (50%)
Set 1 3 1 0 4/30 (13%)
Set 2 0 2 0 2/12 (17%)
Set 3 2 1 0 3/96 (3%)
Total 6 4 2 12/144 (8%)
Table 3 Identified cDNA sequences from Set 3 STACE experiments
Result SAGE tag primer SAGE tag
location
Sequence 5’
mapping
boundary
Sequence 3’
mapping
boundary
GenBank
accession
number
Status (as of WS200)
Full-
length
cDNA P.1
GTTAGGATCGTAGAGGACATG II:8786920 II:8786297 II: 8787044 HQ451870 Overlaps F07H5.4 (pseudogene):
evidence for extension to annotated
exon
Partial
cDNA P.2
AGAGGATTAATTCCCCCCATG II:9375813 II:9376228 II:9375792 HQ451877 Overlaps with C06C3.10
Full-
length
cDNA P.3
GGGGGAAAATCGAAAGACATG II:10201160 II: 10202155 II:10201084 HQ451871 Overlaps with tts-2 (ncRNA): evidence
for new intron
Partial
cDNA 1.1
GAAACGAAGAAGAAAAGCATG V:19434698 V:19434352 V:19434718 HQ451878 Evidence of a novel gene
Full-
length
cDNA 1.2
TTCGACGGCAGATTGTTCATG V:19432707 V:19433037 V:19432406 HQ451872 Overlaps with C25F9.11: evidence for
new 5’ UTR
Full-
length 1.3
TAGCTCAGTCAAAACAACATG V:5812559 V:5813070 V:5812296 HQ451873 Overlaps with ZC250.4: evidence for
extension to 3’ UTR
Partial
cDNA 1.4a
AAAGTTGAGCTTCTGCTCATG X:2346863 X:2335678 X:2346883 HQ451879 Overlaps with T01B6.1: evidence for
new coding sequence
Partial
cDNA
1.4b
AAAGTTGAGCTTCTGCTCATG X:2346863 X:2345479 X:2346883 HQ451880 Overlaps with T01B6.1: evidence for
new transcriptional start site
Partial
cDNA 2.1a
TGGTTGTTAGTAGTGTACATG II:15229391 II:15207408 II:15229412 HQ451881 Overlaps with Y46E12BL.4: evidence
for new 3’ UTR exon
Partial
cDNA
2.1b
TGGTTGTTAGTAGTGTACATG II:15229391 II:15216289 II:15229412 HQ451882 Overlaps with Y46E12BL.4: evidence
for new initial coding exon
Full-
length
cDNA 2.2
CCATCTAAAGGGCTCTACA IV:4415359 IV:44085996 IV:4415616 HQ451874 Overlaps with Y24D9A.1: evidence for
extension to 3’ UTR
Full-
length
cDNA 3.1
CTCATTGAAGGTGAAGCAT X:14690913 X:14692920 X:14690763 HQ451875 Overlaps with sox-3: evidence for
new 3’ UTR
Partial
cDNA 3.2
TGAAATGTCACAGTACACAT III:7604002 III: 7601399 III:7604022 HQ451883 Evidence of a novel gene
Full-
length
cDNA 3.3
GAGAGAATTGTTGTGACCAT X:4681136 X:4682689 X:4680952 HQ451876 Evidence of a novel gene
All data is current as of WS200.
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Figure 3 Candidate cDNA 3.3 alignment. Full length gene model reconstructed for candidate cDNA 3.3. This gene model suggests a
completely novel gene that is missing from WormBase as of WS200.
Figure 4 Candidate DNA 3.1 alignment. Full length gene model reconstructed for candidate cDNA 3.1. This gene model suggests a 3’ UTR
extension to the current sox-3 gene model.
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by FGENESH++. The annotation extension result (full-
length cDNA 3.1) was found to overlap with gene pre-
dictions from each of the utilized programs. However, a
new 3’ UTR exon was shown to be part of this gene
model, and this exon did not overlap with the predic-
tions made by any of the described programs. Addition-
ally, the P.3 result overlapped with an existing ncRNA
gene model. However, the novel intron suggested by
this STACE result was not included in the WormBase
gene model, although it overlaps with AUGUSTUS
prediction.
Conclusions
We have found that the STACE method can be used to
recover accurate full-length gene models. This method
is useful for reconstructing gene models for genes that
have been missed in cDNA sequencing projects and
were missed or mispredicted by gene finders. With the
wide application of next-generation sequencing methods
in the deep sequencing of transcriptomes, more
expressed sequence tags, which indicate the presence of
novel genes will be uncovered. We expect that these
tags will serve as input to the STACE protocol for
further novel gene discovery and determination.
Methods
cDNA library production
Two samples of C. elegans were produced that repre-
sented both a mixed stage population and an embryonic
sample. Tissue samples were put through an RNA extrac-
tion using TRIzol (Invitrogen, SKU# 10296-028). The
cDNA libraries used in this project were created with the
Superscript III reverse transcriptase kit (Invitrogen,
SKU# 18080-085), and the primer used to initiate reverse
transcription was a modified oligo d(T) primer (5’ -
CCAGACACTATGCTCATACGACGCAGT(16) VN - 3’)
(Invitrogen). The protocol accompanying the kit was fol-
lowed, and the samples were treated with Ribonuclease
H (Invitrogen, SKU# 18021-014).
Amplification of tag ends
The reverse complement of each SAGE tag sequence
was used to design the SAGE tag primers. These pri-
mers were used in conjunction with a primer based on
the SL1 sequence (5’ - GGTTTAATTACCCAAGTTT-
GAG - 3’) in a PCR. The PCR was initiated with a 94°C
melt step for 2 minutes, followed by 32 cycles of a 94°C
melt step for 15 seconds, a 60°C annealing step for 45
seconds, and a 72°C extension step for 1 minute. This
Figure 5 Candidate cDNA P.3 alignment. Full length gene model reconstructed for candidate cDNA P.3. This gene model suggests revision of the
structure to the tts-2 gene model, and also that this transcript is polyadenylated, a feature that is commonly associated with protein-coding genes.
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was followed by a final extension at 72°C for 5 minutes.
A Taq polymerase provided by Dr. Harald Hutter was
used in all of the PCRs. Amplicons produced by the
PCRs were visualized with a 1% gel electrophoresis, and
extracted with a QIAquick Gel Extraction kit (Qiagen,
ID 28704). These amplicons were then cloned with the
InsTAclone kit (Fermentas, #K1214). Cloned amplicons
were submitted for sequencing (Macrogen, Seoul,
Korea), and returned sequences were mapped back to
the C. elegans genome with the BLAT tool [25] on the
WormBase website http://www.wormbase.org/. We
opted to use BLAT instead of other alignment tools
because this program can take spliced mRNA sequences
(i.e. STACE cloned sequences) and align them to the
genome in a way that reflects intron - exon boundaries
[25,35]. Those amplicons whose sequence alignment
indicated a true positive result were then further stu-
died. The returned sequence was used to design an
internal primer that would be compatible with the uni-
versal primer (5’ - CACTATGCTCATACGACGCAGT -
3’). These primers were then used in a PCR with the
same parameters described above to produce the down-
stream amplicons needed for full-length characteriza-
tion. Internal primers were designed using the Primer3
program [28].
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